Results 131 to 140 of about 1,690 (152)

Lomitapide in paediatric patients with homozygous familial hypercholesterolaemia (HoFH) – Analysis of long-term (104-week) safety and efficacy from the APH-19 study

Atherosclerosis Plus
P. Dawson, Luis Masana, Alberto Zambon, C. Schmitt, Christina Taylan, J. Driemeyer, Hofit Cohen, P. Buonuomo, A. Alashwal, M. Al-Dubayee, Naji Kholaif, J. Díaz-Díaz, Faouzi Maatouk, Sergio Martínez-Hervás, Brian Mangal, Sandra Löwe, Zsuzsanna Tamas   +16 more
semanticscholar   +1 more source

† Real-world safety and effectiveness of lomitapide in homozygous familial hypercholesterolemia over 10 years: Data from LOWER

Journal of Clinical Lipidology
J. Underberg, Christopher Cannon, Dominique Larrey, Lukas Makris, Inbar Aviezer, Ruth Louzado, Sandra Löwe, Sallyann O’Brien, Dirk Blom   +8 more
semanticscholar   +1 more source

Lomitapide and Mipomersen—Inhibiting Microsomal Triglyceride Transfer Protein (MTP) and apoB100 Synthesis

Current Atherosclerosis Reports, 2019
Dirk J Blom, Frederick J Raäl, Raúl D Santos   +2 more
exaly  

† Lomitapide in pediatric patients with HoFH – analysis of long-term (104-week) safety and efficacy from the APH-19 study

Journal of Clinical Lipidology
Alberto Zambon, C. Schmitt, Christina Taylan, J. Driemeyer, Hofit Cohen, P. Buonuomo, A. Alashwal, M. Al-Dubayee, J. Díaz-Díaz, Faouzi Maatouk, Sergio Martínez-Hervás, Brian Mangal, Naji Kholaif, Sandra Löwe, Zsuzsanna Tamas, Luis Masana   +15 more
semanticscholar   +1 more source

Clinical experience of lomitapide therapy in patients with homozygous familial hypercholesterolaemia

Atherosclerosis Supplements, 2014
Marina Cuchel, Dirk J Blom, Maurizio Averna   +2 more
exaly  

Treatment of Familial Chylomicronaemia Syndrome with Lomitapide

Atherosclerosis Plus
N. Lorde, A. Ochoa-Ferraro, S. Wanninayake, L. Robertson, C. Dawson   +4 more
semanticscholar   +1 more source

Pharmacokinetics and Pharmacodynamics of Lomitapide in Japanese Subjects

Journal of Atherosclerosis and Thrombosis, 2016
Jörg Täubel, Ulrike Lorch
exaly  

LOWER, a registry of lomitapide-treated patients with homozygous familial hypercholesterolemia: Rationale and design

Journal of Clinical Lipidology, 2016
Dirk J Blom, Zahi A Fayad, Lukas Makris
exaly  

Efficacy of Lomitapide in the Treatment of Familial Homozygous Hypercholesterolemia: Results of a Real-World Clinical Experience in Italy

Advances in Therapy, 2017
Laura D’Erasmo, Angelo Baldassare Cefalù, Davide Noto   +2 more
exaly  

Lomitapide: navigating cardiovascular challenges with innovative therapies

Molecular Biology Reports
U. Munkhsaikhan, K. Ait-Aissa, Amal M. Sahyoun, E. Apu, A. Abidi, A. Kassan, M. Kassan   +6 more
semanticscholar   +1 more source